Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | LFA102 |
Synonyms | |
Therapy Description |
LFA102 is a monoclonal antibody to the extracellular domain of the prolactin receptor (PRLR) that may inhibit growth of prolactin dependent tumors (PMID: 23270929, PMID: 27091421, PMID: 32878811). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
LFA102 | LFA 102|LFA-102 | LFA102 is a monoclonal antibody to the extracellular domain of the prolactin receptor (PRLR) that may inhibit growth of prolactin dependent tumors (PMID: 23270929, PMID: 27091421, PMID: 32878811). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|